Andreas Rummelt - Net Worth and Insider Trading
Andreas Rummelt Net Worth
The estimated net worth of Andreas Rummelt is at least $2 Million dollars as of 2024-11-06. Andreas Rummelt is the Director of Alexion Pharmaceuticals Inc and owns about 12,786 shares of Alexion Pharmaceuticals Inc (ALXN) stock worth over $2 Million. Details can be seen in Andreas Rummelt's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Andreas Rummelt has not made any transactions after 2014-08-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Andreas Rummelt
Andreas Rummelt Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Andreas Rummelt owns 1 companies in total, including Alexion Pharmaceuticals Inc (ALXN) .
Click here to see the complete history of Andreas Rummelt’s form 4 insider trades.
Insider Ownership Summary of Andreas Rummelt
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ALXN | Alexion Pharmaceuticals Inc | 2020-05-14 | director |
Andreas Rummelt Latest Holdings Summary
Andreas Rummelt currently owns a total of 1 stock. Andreas Rummelt owns 12,786 shares of Alexion Pharmaceuticals Inc (ALXN) as of August 25, 2014, with a value of $2 Million.
Latest Holdings of Andreas Rummelt
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALXN | Alexion Pharmaceuticals Inc | 2014-08-25 | 12,786 | 182.50 | 2,333,445 |
Holding Weightings of Andreas Rummelt
Andreas Rummelt Form 4 Trading Tracker
According to the SEC Form 4 filings, Andreas Rummelt has made a total of 0 transactions in Alexion Pharmaceuticals Inc (ALXN) over the past 5 years. The most-recent trade in Alexion Pharmaceuticals Inc is the sale of 5,052 shares on August 25, 2014, which brought Andreas Rummelt around $861,518.
Insider Trading History of Andreas Rummelt
- 1
Andreas Rummelt Trading Performance
GuruFocus tracks the stock performance after each of Andreas Rummelt's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Andreas Rummelt is 7.65%. GuruFocus also compares Andreas Rummelt's trading performance to market benchmark return within the same time period. The performance of stocks bought by Andreas Rummelt within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Andreas Rummelt's insider trading performs compared to the benchmark.
Performance of Andreas Rummelt
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -1.41 | | | | | |
| Relative Return to S&P 500(%) | 4.88 | | | | | |
Andreas Rummelt Ownership Network
Ownership Network List of Andreas Rummelt
Ownership Network Relation of Andreas Rummelt
Andreas Rummelt Owned Company Details
What does Alexion Pharmaceuticals Inc do?
Who are the key executives at Alexion Pharmaceuticals Inc?
Andreas Rummelt is the director of Alexion Pharmaceuticals Inc. Other key executives at Alexion Pharmaceuticals Inc include SVP & Controller & CAO Daniel Bazarko , EVP & CCAO Tanisha Carino , and EVP & Chief Commercial Officer Brian Goff .
Alexion Pharmaceuticals Inc (ALXN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Alexion Pharmaceuticals Inc (ALXN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Alexion Pharmaceuticals Inc (ALXN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Alexion Pharmaceuticals Inc (ALXN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alexion Pharmaceuticals Inc Insider Transactions
Andreas Rummelt Mailing Address
Above is the net worth, insider trading, and ownership report for Andreas Rummelt. You might contact Andreas Rummelt via mailing address: C/o Alexion Pharmaceuticals, Inc. 352 Knotter Drive Cheshire Ct 06410.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
